Tarsus Pharmaceuticals annual operating margin
2021
2022
2023
2024
2025
Tarsus Pharmaceuticals's operating margin was −15.72% for fiscal 2025.
View full Tarsus Pharmaceuticals company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −15.72% | +50.18 pp |
| 2024 | 2024-12-31 | −65.90% | +754.63 pp |
| 2023 | 2023-12-31 | −820.53% | −577.61 pp |
| 2022 | 2022-12-31 | −242.92% | −221.60 pp |
| 2021 | 2021-12-31 | −21.32% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −11.45% | +10.16 pp |
| Q1 2026 | 2026-03-31 | −3.78% | +29.77 pp |
| Q4 2025 | 2025-12-31 | −5.26% | +31.52 pp |
| Q3 2025 | 2025-09-30 | −12.24% | +40.05 pp |
| Q2 2025 | 2025-06-30 | −21.61% | +59.99 pp |
| Q1 2025 | 2025-03-31 | −33.55% | +102.92 pp |
| Q4 2024 | 2024-12-31 | −36.77% | +303.16 pp |
| Q3 2024 | 2024-09-30 | −52.29% | +2135.58 pp |
| Q2 2024 | 2024-06-30 | −81.60% | +916.48 pp |
| Q1 2024 | 2024-03-31 | −136.47% | +14.14 pp |
| Q4 2023 | 2023-12-31 | −339.94% | −305.74 pp |
| Q3 2023 | 2023-09-30 | −2,187.87% | +1433.84 pp |
| Q1 2023 | 2023-03-31 | −998.08% | +3276.48 pp |
| Q4 2022 | 2022-12-31 | −150.61% | +1115.92 pp |
| Q2 2022 | 2022-06-30 | −34.20% | −67.27 pp |
| Q1 2022 | 2022-03-31 | −3,621.71% | −3653.75 pp |
| Q4 2021 | 2021-12-31 | −4,274.56% | — |
| Q3 2021 | 2021-09-30 | −1,266.53% | — |
| Q2 2021 | 2021-06-30 | 33.07% | — |
| Q1 2021 | 2021-03-31 | 32.05% | — |
Across the available reported history, Tarsus Pharmaceuticals's operating margin increased from −65.90% to −15.72%, a change of +50.18 percentage points. The latest reported quarter, Q2 2026, shows −11.45%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tarsus Pharmaceuticals filings at SEC.gov ↗